Clinicians! Come to the next Las Vegas MSK Ultrasound and Orthobiologics Course
*Registration Is Now Open!*
The next Las Vegas MSK Ultrasound and Orthobiologics will be July 30 – August 1, 2020 at the Cosmopolitan Hotel on the Strip
Early registration for the 2.5 day course is $2000 and we have a great group room rates also.

Expect to see 20 all star faculty, 75 participants, 35 models, 35 ultrasound machines, 8 hours of hands on scanning with live models.

*The HYP Knee Study* Now enrolling patients with knee arthritis pain!

The HYP study is our first clinical study in 2020 and is approved and enrolling patients!

We are trying to help patients with knee pain, stiffness, and weakness from degenerative joint disease (arthritis).

Our study is evaluating two different treatment injection options to see which one gives patients better pain relief.
The best part for our patients? There is no cost to be in the study.
Please call our study coordinators at 877-211-4471 for more information.

Interested in recent FDA action against regenerative medicine sellers, clinics and doctors?

For patients and clinicians interested in seeing just some of the FDA enforcement actions against some clinics and sellers….here you go.
Sadly, there are even more than listed here!
The point is to make sure you are seeing an orthopedist for an orthopedic issue.
Make sure the person making surgical or non surgical decisions is a surgeon who does the surgeries. (FDA action against Chara Biologics) (FDA action against Liveyon) (FDA on exosomes) (FDA action against US Stem Cell and adipose) (FDA action against Cell Surgical Network and adipose) (FDA on institutional review boards) (FDA action against Richsource Stem Cells) (FDA action against Cord For Life and umbilical cord) (FDA action against Stemgenex and umbilical cord) (FDA opinion on whartons jelly) (FDA action against R3 Stem Cells)

Another “Amniotic Fluid/Umbilical Cord Blood/Wharton’s Jelly, Exosome” Sales Company Gets Stopped By The FDA

This time, the company is RichSource Stem Cells, whose CEO is Sara Oracle. On November 20, 2019, the FDA sent the company a letter detailed all of the falsehoods in the claims being mad by these companies when they sell their products to clinicians….and all the falsehoods that clinicians are selling patients when then sell these products. These products simply cannot be used in humans in the USA without FDA approval and 99% do not (Amniofix from a company called MiMedx has an approval for study and use for knee arthritis only) All of the rest of the companies should know better and are putting people’s health and safety secondary to their own profit motive.
This is why we only use bone marrow concentrate…from your own body….as the source for stem cells, and growth factors, another proteins and cytokines when we do our procedures at the Texas Orthobiologic Institute.RIchSource FDA Letter 11.20.19